Drug Trial Radar · NCT07444086
QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia
Last checked: Nov 19, 2026Latest source record: Mar 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
510
Planned (sponsor's estimate)
Start
Mar 5, 2026
Primary completion
Oct 7, 2027
Study completion Feb 28, 2028
Sponsor
- Lead sponsor
- Qilu Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase III clinical trial aims to assess the efficacy and safety of QLC7401 monotherapy in adults with non-familial primary hypercholesterolemia or mixed dyslipidemia who are not receiving lipid-lowering therapy. Participants will be randomly assigned to receive subcutaneous injections of either QLC7401 or a placebo according to the study schedule.
Conditions
- Primary Hypercholesterolemia or Mixed Hyperlipidemia
Interventions
QLC7401Drug
QLC7401 Injection
PlaceboDrug
Placebo matching QLC7401 in appearance and administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Low Density Lipoprotein Cholesterol (LDL-C) from BaselineTime frame: From baseline to Day 330
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.